Health-care companies rose, but not by as much as the broad market, as defensively minded traders rotated into the utilities sector.
Novavax, the pharmaceutical company that last year warned that falling sales of its Covid-19 vaccine could put it out of business, said it reached a $1.4 billion deal with French company Sanofi to commercialize its existing treatment and develop a new one.
Organogenesis Holdings shares rose after the company reported a narrower loss for the first quarter along with higher revenue.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
05-10-24 1701ET
